{"article": [{"url": "https://www.marketwatch.com/story/shares-of-moderna-catalent-gain-on-vaccine-manufacturing-deal-2020-06-25", "published": 1593072860.0, "headline": "Shares of Moderna, Catalent gain on vaccine manufacturing deal", "body": "Shares of Moderna Inc. MRNA, +0.09% gained 2.6% in premarket trading on Thursday after the company said that Catalent Inc. CTLT, +1.90% will handle vial filling and packaging for its COVID-19 vaccine candidate if it proves to be safe and efficacious. Catalent's stock was up 9.2%. The companies developing vaccines for the coronavirus are already setting up manufacturing deals in order to speed up the time it takes to get vaccines into the public, even before the now investigational vaccines make it through the clinical-trial process. Since the start of the year, Moderna's stock has soared 231.5%, shares of Catalent are up 25.1%, and the S&P 500 SPX, +0.87% is down 5.6%."}]}